Catalyst Biosciences
AcquiredGyre Therapeutics – Focused on organ fibrosis and inflammatory disease
South San Francisco, United States · Founded 2000 · $100.4M raised
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2000
- Business Model
- B2B
- Website
- catalystbiosciences.com
- Total Funding
- $100.4M
- Last Round
- $30.0M Corporate RoundJan 2011
- Rounds
- 3
- Acquisition Date
- Oct 2023
About
Catalyst Biosciences was a South San Francisco-based biopharmaceutical company focused on developing protein therapeutics for rare bleeding disorders including hemophilia. In 2023, GC Biopharma acquired Catalyst's rare hematology pipeline assets while Catalyst completed a reverse merger with GNI Group's Beijing Continent Pharmaceuticals, pivoting to fibrosis treatments.
Summary
Catalyst Biosciences is a Biotech company based in South San Francisco, United States, founded in 2000. It has raised $100.4M in total across 3 rounds, most recently a $30.0M Corporate Round round in Jan 2011. Investors include Essex Woodlands Health Ventures, Burrill & Company and HealthCare.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2023
Sign up to see all 6 rounds
Series B through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/catalyst-biosciences"><img src="https://indexed.vc/api/badge/company/catalyst-biosciences" alt="Catalyst Biosciences on Indexed.vc" width="260" height="76" /></a>